Carfilzomib, Lenalidomide, and Dexamethasone for Smoldering Multiple Myeloma

Clinical trial NCT01572480 · COMPLETED

Trial details

NCT number: NCT01572480
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2012-05-29
Primary completion: 2022-03-03
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.